Mechanisms of podocyte injury and implications for diabetic nephropathy

F Barutta, S Bellini, G Gruden - Clinical Science, 2022 - portlandpress.com
Albuminuria is the hallmark of both primary and secondary proteinuric glomerulopathies,
including focal segmental glomerulosclerosis (FSGS), obesity-related nephropathy, and …

Cardiovascular effects of marijuana and synthetic cannabinoids: the good, the bad, and the ugly

P Pacher, S Steffens, G Haskó, TH Schindler… - Nature Reviews …, 2018 - nature.com
Dysregulation of the endogenous lipid mediators endocannabinoids and their G-protein-
coupled cannabinoid receptors 1 and 2 (CB1R and CB2R) has been implicated in a variety …

Bioactive lipids, inflammation and chronic diseases

A Leuti, D Fazio, M Fava, A Piccoli, S Oddi… - Advanced Drug Delivery …, 2020 - Elsevier
Endogenous bioactive lipids are part of a complex network that modulates a plethora of
cellular and molecular processes involved in health and disease, of which inflammation …

From phytocannabinoids to cannabinoid receptors and endocannabinoids: pleiotropic physiological and pathological roles through complex pharmacology

A Ligresti, L De Petrocellis… - Physiological …, 2016 - journals.physiology.org
Apart from having been used and misused for at least four millennia for, among others,
recreational and medicinal purposes, the cannabis plant and its most peculiar chemical …

Endocannabinoid signaling at the periphery: 50 years after THC

M Maccarrone, I Bab, T Bíró, GA Cabral, SK Dey… - Trends in …, 2015 - cell.com
In 1964, the psychoactive ingredient of Cannabis sativa, Δ 9-tetrahydrocannabinol (THC),
was isolated. Nearly 30 years later the endogenous counterparts of THC, collectively termed …

[HTML][HTML] The therapeutic potential of second and third generation CB1R antagonists

R Cinar, MR Iyer, G Kunos - Pharmacology & therapeutics, 2020 - Elsevier
Endocannabinoids acting via CB 1 receptors (CB 1 R) play a critical role in regulating
energy homeostasis, which was the rationale for the pharmaceutical development of CB 1 R …

Role of the endocannabinoid system in diabetes and diabetic complications

G Gruden, F Barutta, G Kunos… - British journal of …, 2016 - Wiley Online Library
Increasing evidence suggests that an overactive endocannabinoid system (ECS) may
contribute to the development of diabetes by promoting energy intake and storage, impairing …

G protein–coupled receptors targeting insulin resistance, obesity, and type 2 diabetes mellitus

DM Riddy, P Delerive, RJ Summers, PM Sexton… - Pharmacological …, 2018 - Elsevier
G protein–coupled receptors (GPCRs) continue to be important discovery targets for the
treatment of type 2 diabetes mellitus (T2DM). Many GPCRs are directly involved in the …

The contribution of lipotoxicity to diabetic kidney disease

JR Schelling - Cells, 2022 - mdpi.com
Lipotoxicity is a fundamental pathophysiologic mechanism in diabetes and non-alcoholic
fatty liver disease and is now increasingly recognized in diabetic kidney disease (DKD) …

Neuroprotection in oxidative stress-related neurodegenerative diseases: role of endocannabinoid system modulation

J Paloczi, ZV Varga, G Hasko… - Antioxidants & redox …, 2018 - liebertpub.com
Significance: Redox imbalance may lead to overproduction of reactive oxygen and nitrogen
species (ROS/RNS) and subsequent oxidative tissue damage, which is a critical event in the …